CA Stock MarketDetailed Quotes
MDNA Medicenna Therapeutics Corp
- 1.720
- -0.060-3.37%
15min DelayMarket Closed Nov 29 16:00 ET
134.43MMarket Cap-4526P/E (TTM)
1.800High1.660Low57.78KVolume1.800Open1.780Pre Close99.94KTurnover2.98052wk High0.11%Turnover Ratio78.16MShares0.38052wk Low-0.38EPS TTM87.70MFloat Cap7.250Historical HighLossP/E (Static)50.99MShs Float0.215Historical Low-0.37EPS LYR7.87%Amplitude--Dividend TTM6.69P/B1Lot Size--Div YieldTTM
Medicenna Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -43.15%-5.61M | 32.87%-2.33M | -28.47%-16.26M | -111.48%-4.85M | -10.09%-4.03M | 10.95%-3.92M | -50.39%-3.47M | 46.33%-12.66M | 20.92%-2.29M | 46.05%-3.66M |
| Net income from continuing operations | -11.85%-4.16M | -27.08%-3.64M | -153.44%-25.47M | -260.58%-13.9M | -336.20%-4.98M | -315.51%-3.72M | 31.12%-2.86M | 55.49%-10.05M | -20.27%-3.86M | 76.26%-1.14M |
| Operating gains losses | -2.71%-986K | 94.26%-72K | 257.48%8.24M | 647.08%10.38M | 102.12%73K | 68.14%-960K | -646.43%-1.25M | -4,422.31%-5.23M | --1.39M | ---3.44M |
| Depreciation and amortization | 1,000.00%11K | 400.00%5K | 0.00%4K | 0.00%1K | 0.00%1K | -50.00%1K | --1K | -89.47%4K | -87.50%1K | -90.00%1K |
| Remuneration paid in stock | 145.69%656K | 46.28%433K | -11.82%1.21M | 151.03%487K | -53.24%159K | -37.91%267K | -27.27%296K | -3.11%1.37M | -15.28%194K | -20.00%340K |
| Other non cashItems | ---- | ---- | 15.46%-984K | ---- | ---- | ---- | -163.64%-29K | -57.94%-1.16M | -49.50%-1.04M | -170.00%-27K |
| Change In working capital | -343.44%-1.13M | 148.16%943K | -69.25%741K | -180.35%-822K | 18.09%718K | 155.23%465K | -76.56%380K | 230.69%2.41M | 33.03%1.02M | 125.38%608K |
| -Change in receivables | 137.42%58K | -123.02%-218K | 36.31%1.68M | 60.38%340K | -1.80%546K | 90.50%-155K | -54.80%947K | 414.03%1.23M | -56.38%212K | -18.11%556K |
| -Change in payables and accrued expense | -291.94%-1.19M | 304.76%1.16M | -179.47%-937K | -243.28%-1.16M | 230.77%172K | -21.52%620K | -19.62%-567K | 181.20%1.18M | 186.57%811K | 101.69%52K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -43.15%-5.61M | 32.87%-2.33M | -28.47%-16.26M | -111.48%-4.85M | -10.09%-4.03M | 10.95%-3.92M | -50.39%-3.47M | 46.33%-12.66M | 20.92%-2.29M | 46.05%-3.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2K | -31K | 0 | 0 | ||||||
| Net PPE purchase and sale | ---2K | ---31K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---2K | ---31K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 706K | 20.9M | 0 | 0 | 0 | 0 | 0 | 538.47%24.76M | -322.35%-189K | -96.09%136K |
| Net common stock issuance | --0 | --19.71M | --0 | --0 | --0 | --0 | --0 | 605.61%24.76M | --0 | -101.56%-53K |
| Proceeds from stock option exercised by employees | --706K | --1.18M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --706K | --20.9M | --0 | --0 | --0 | --0 | --0 | 538.47%24.76M | -322.35%-189K | -96.09%136K |
| Net cash flow | ||||||||||
| Beginning cash position | 20.31%35.63M | -49.45%16.98M | 63.60%33.6M | -39.82%21.76M | -35.80%25.69M | 53.42%29.62M | 63.60%33.6M | -32.40%20.54M | 54.55%36.15M | 139.73%40.01M |
| Current changes in cash | -25.20%-4.91M | 634.54%18.54M | -234.35%-16.26M | -95.36%-4.85M | -14.34%-4.03M | -120.17%-3.92M | -159.39%-3.47M | 225.34%12.1M | 11.81%-2.48M | -152.50%-3.52M |
| Effect of exchange rate changes | -4,100.00%-294K | 121.25%109K | -136.95%-354K | 189.61%69K | 128.96%97K | -100.55%-7K | -588.57%-513K | 620.65%958K | -71.11%-77K | -8,275.00%-335K |
| End cash Position | 18.45%30.43M | 20.31%35.63M | -49.45%16.98M | -49.45%16.98M | -39.82%21.76M | -35.80%25.69M | 53.42%29.62M | 63.60%33.6M | 63.60%33.6M | 54.55%36.15M |
| Free cash from | -43.20%-5.62M | 31.98%-2.36M | -28.47%-16.26M | -111.48%-4.85M | -10.09%-4.03M | 10.95%-3.92M | -50.39%-3.47M | 46.33%-12.66M | 20.92%-2.29M | 46.05%-3.66M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data